34th week of 2015 patent applcation highlights part 7 |
Patent application number | Title | Published |
20150230990 | Reduced-Pressure Dressings, Systems, And Methods With Evaporative Devices - Wounds dressings, systems, and methods are presented for removing liquid from a wound site into a dressing and moving air through the dressing to evaporate at least a portion of the removed liquid. The air is moved in one instance by a Coanda device incorporated into the dressing. Other systems, dressings, and methods are presented. | 2015-08-20 |
20150230991 | Reduced-Pressure Wound Dressings - Systems, methods, and dressings for treating a linear wound, such as an incision, on a patient are presented. The systems, dressings, and methods involve a sealed wound dressing assembly that helps form a fluid seal around the linear wound while simultaneously encompassing a subcutaneous delivery conduit to deliver fluid to or from a subcutaneous tissue site. In one instance, a reduced-pressure interface is used to allow the subcutaneous delivery conduit to pass through tissue at or near the linear wound and through a wound dressing assembly to a drainage receptacle. | 2015-08-20 |
20150230992 | PROCEDIMENTO DI REALIZZAZIONE DI UNA MEMBRANA DI INTERFACCIA PER IL CONTATTO CON LA PELLE - Provided is a production method for an interface membrane for contact with the skin, configured to be connected to a support layer and to be placed in contact with the human body, the interface membrane having a structure with a main two-dimensional extension and defining a first surface configured to come into contact with the skin, the membrane including at least one layer defining the first surface and made of crosslinked polyurethane foam, the method including at least one coating step of the polyurethane foam on a transfer medium, to make said at least one layer, a detachment step of said interface membrane from said transfer medium, said transfer medium having a roughness equivalent to a transfer paper with less than 4% gloss, measured using the 75° TAPPI T480 method. | 2015-08-20 |
20150230993 | Methods of Making Bulked Absorbent Members - Absorbent members, especially bulked absorbent members, and methods of making the same are disclosed. The absorbent member may be in the form of a unitary absorbent fibrous layer comprising at least some cellulose fibers. The unitary absorbent fibrous layer is at least partially stratified through its thickness. The absorbent member may also have a plurality of discrete deformations, such as depressions and/or apertures in its surfaces. The method involves subjecting a precursor web to at least one cycle (or pass) through a mechanical deformation process. The mechanical deformation process utilizes a first forming member and a second forming member that form a nip therebetween through which the precursor web is passed. The first and second forming members are moving at different speeds relative to each other when they come together to form the nip. | 2015-08-20 |
20150230994 | MACHINE FOR MAKING ABSORBENT SANITARY ARTICLES - A machine for making absorbent sanitary articles such as nappies for babies or incontinence pads for adults, sanitary towels and the like, comprises a programmable electronic controller device comprising a shift register and at least one optical inspection system connected to the programmable electronic controller device; the programmable electronic controller device generates a synchronism signal having a train of consecutive pulses defining a machine step, a trigger signal for activating the optical inspection system in a synchronised fashion with the synchronism signal and a shift register shift command within a machine step, the programmable electronic controller device also generates an identifier which is uniquely associated with the article inspected by the optical inspection system and sends that identifier with the trigger signal to the optical inspection system; the optical inspection system receives the identifier and, when a response time has elapsed, associates reject information with the respective identifier. | 2015-08-20 |
20150230995 | DISPOSABLE DIAPER - A disposable diaper includes a waist opening and a pair of leg openings with a composite stretchable member. The composite stretchable member includes first and second nonwoven fabric sheet parts and elastic members arranged therebetween. Each of the first and second nonwoven fabric sheet parts is provided with a plurality of convex-concave regions including convex and concave parts. At least one non-shaped region separates the convex-concave regions from each other in the longitudinal direction. The first and second nonwoven fabric sheet parts are overlaid so that the convex-concave regions of the first nonwoven fabric sheet part and the second nonwoven fabric sheet part adjoin each other and the non-shaped regions of the first nonwoven fabric sheet part and the second nonwoven fabric sheet part are separated from each other and are joined with each other by an adhesive applied to the elastic members. | 2015-08-20 |
20150230996 | DISPOSABLE PULL-ON GARMENT - An absorbent article having a longitudinal centerline, a front region, a crotch region, and a back region. The absorbent article has a main portion, a side portion, and a waist portion. The waist portion has a belt portion that has a front belt portion having elastomeric material and a back belt portion having elastomeric material. The front belt portion has a first elastic section and a second elastic section, each section having force zones. The back belt portion has a third elastic section and a fourth elastic section, each section having force zones. The force zones in the portions alternate between a high force zone and a low force zone in at least one belt portion. | 2015-08-20 |
20150230997 | ABSORBENT ARTICLE WITH NEW LEG GATHERS - An absorbent article including: a leak preventer sheet form; an absorber capable of absorbing bodily fluid, wherein minimum one layer is above the leak preventer; a surface sheet covers part of the absorber upper surface and includes a liquid impermeable area; right and left floating leg gathers above the absorber, from front to rear end parts in length direction of the absorbent article body via a front body, a crotch part and rear body, wherein floating leg gather has a head and hanging parts connects to the head part, wherein a front and rear end parts of the floating leg gather are respectively coupled to the front and rear end parts vicinity of the absorbent article body, the hanging part hanging from the head part toward the absorber; wherein a transferring passage is formed by coupling each hanging part of the right and left floating leg gathers to the surface sheet. | 2015-08-20 |
20150230998 | ABSORBENT ARTICLE - The present invention addresses the problem of providing an absorbent article that has an improved ability to transfer menstrual blood from a liquid-permeable layer to an absorbent body and can reduce the amount of the menstrual blood remaining in the liquid-permeable layer. To solve this problem, provided is a sanitary napkin provided with a top sheet, a back sheet and an absorbent body that is interposed between the top sheet and the back sheet, wherein convex portions formed in an excretion orifice contact region of the top sheet are coated with a blood lubricity-imparting agent that has a kinetic viscosity of 0.01-80 mm | 2015-08-20 |
20150230999 | DISPOSABLE ABSORBENT ARTICLE WITH ABSORBENT PARTICULATE POLYMER MATERIAL DISTRIBUTED FOR IMPROVED ISOLATION OF BODY EXUDATES - A disposable absorbent article is provided having an absorbent core located in a chassis and including absorbent particulate polymer material defining at least one cavity for improved isolation of fecal matter or other body exudates. The absorbent core may be substantially cellulose free. Methods for making such an absorbent core and corresponding disposable absorbent article are also disclosed. | 2015-08-20 |
20150231000 | ABSORBENT ARTICLE - The present invention addresses the problem of providing an absorbent article that is provided with a liquid-permeable layer, said liquid-permeable layer having convex portions that are hollow inside, has an improved ability to transfer menstrual blood from the liquid-permeable layer to an absorbent body and can reduce the amount of the menstrual blood remaining in the liquid-permeable layer (in particular, the internal cavities in the convex portions). To solve this problem, provided is a sanitary napkin provided with a liquid-permeable top sheet, a liquid-impermeable back sheet and an absorbent body that is interposed between the top sheet and the back sheet, wherein convex portions, said convex portions being hollow inside and formed in an excretion orifice contact region of the top sheet, are coated with a blood lubricity-imparting agent that has a kinetic viscosity of 0.01-80 mm | 2015-08-20 |
20150231001 | OPERATION DEVICE AND ELECTRIC MOBILITY - There is provided an operation device provided with: an operation member displaceable by an operator; a two-dimensional support mechanism in which a pair of one-dimensional support mechanisms that individually displaceably supports the operation member | 2015-08-20 |
20150231002 | Adjustment Device for Vehicle Seats - The invention relates to an adjustment device for vehicle seats, in particular for power driven wheelchairs or rehabilitation vehicles, comprising at least one mounting plate and one bearing plate with a lifting device. In order to allow for an individual adjustment of the seat, the lifting device consists of two to four scissor fittings, which are adjustable in height by driving means. Depending on the height setting of each scissor fitting, a lateral inclination or a tilting forwards or backwards can be achieved in addition to the lifting and lowering. | 2015-08-20 |
20150231003 | WHEELCHAIR INCLUDING A COLLAPSIBLE AND/OR ANGLE ADJUSTABLE BACKREST FRAME - The present invention relates to a wheelchair ( | 2015-08-20 |
20150231004 | WHEELCHAIR INCLUDING A TILTABLE SEAT - An exemplary wheelchair comprises a main frame and a seat frame. Drive wheels and pivoting caster wheels are affixed to and support the main frame. The seat frame is connected to the main frame via left and right rear linkage arms, each rear linkage arm having a first end pivotally connected to the main frame and a second end pivotally connected to the seat frame, thereby allowing the seat frame to pivot relative to the main frame around a virtual pivot point. A seat plate having right, left, front, and rear sides is supported by the seat frame. A backrest frame is also connected to the seat frame. Left and right guide slots of the seat frame receive left and right guide rollers rotationally arranged at each end of a laterally oriented shaft connected to the main frame. The rear linkage arms and guide slots are configured so the virtual pivot point of the seat frame moves rearward when the seat frame is moved from an upright position to a tilted position. | 2015-08-20 |
20150231005 | PERSONAL INDEPENDENT MOBILITY AND LIFT DEVICE - A mobility device with sit and stand assist for providing disabled individuals with the ability to rise from a sitting position and move about without the aid of an assistant. The mobility device with sit and stand assist generally includes a motorized and steerable Drive Carriage Assembly, a Trailing Cart Assembly attached to the Drive Carriage Assembly, an Outrigger Assembly attached to the Trailing Cart Assembly, a Lift Arm Assembly attached to the Outrigger Assembly, a Lift Arm Locking Bolt Assembly attached to the Lift Arm Assembly, a Knee Brace Assembly attached to the Trailing Cart Assembly, a Control Assembly attached to the Lift Arm Assembly, and a User Connection Group comprised of various components designed to enable the user to comfortably connect himself/herself to the Device such that the user might be able to utilize and benefit from the Device. | 2015-08-20 |
20150231006 | COMMUNICATION METHODS FOR PATIENT HANDLING DEVICES - Patient care devices, such as person support apparatuses and thermal control units, include one or more internal high speed networks, such as an Ethernet, for transmitting data between internal nodes or modules. A lower speed network may also be included with the Ethernet for redundantly transmitting some, but not all, types of data. Devices external to the patient care device can be granted limited access to the internal high speed network. Such devices may connect to the high speed network to utilize one or more user interfaces of the patient care device and/or to piggyback onto the patient care device's connection to an external local area network (e.g. a hospital LAN), or the patient care device's connection to yet another device. Some nodes may include web servers for serving up web pages of diagnostic information relevant to that node. The web servers are accessible via an external web browser. | 2015-08-20 |
20150231007 | LOW-AIR-LOSS (LAL) PATIENT SUPPORT APPARATUSES AND METHODS - Mattresses and cushions, methods of making mattresses and cushions, and patient supports comprising a mattress and/or a cushion. At least some embodiments of the present mattresses and cushions comprise a body with air-impermeable material having a plurality of openings, and a cover sheet comprising air-permeable and liquid-impermeable material covering at least a portion of the plurality of openings and coupled to the body by a liquid-impermeable welded seam encircling the covered one or more openings. | 2015-08-20 |
20150231008 | SYSTEM FOR PROPELLING HOSPITAL BED - A system for propelling a hospital bed comprising a controller connected via the fifth wheel control unit to the auxiliary drive. The controller can be located at any place on the hospital bed. For better placement in various places it is possible to use a docking member, which may contain a sensor detecting the insertion of the controller in the docking member. The controller may contain a greater number of user-activated buttons of various types. | 2015-08-20 |
20150231009 | Patient lifter with intraoperative controlled temperautre air delivery system - A combination patient-transfer and intraoperative heater device has a top and bottom chamber separated by a barrier. The patient rests on the top chamber, which has a plurality of apertures for discharge of temperature-controlled filtered heated or cooled air at a regulated pressure for patient comfort and mitigation of infection. Heated or cooled filtered air is delivered to the area surrounding the patient, maintaining body temperature during anaesthesia. The bottom chamber has a plurality of apertures. When air pressure is low or off, the bottom chamber is flat and un-inflated. When air pressure is increased, air enters the bottom chamber and the apertures emit air, creating an air cushion facilitating lateral movement of the lifter device. The device performs two functions that now require separate devices and air blowers, it saves space and reduces both costs and complexity in the operating room while mitigating risk of infection. | 2015-08-20 |
20150231010 | PATIENT REPOSITIONING SYSTEM - A patient repositioning device includes an upper body support and a lower body support which are generally planar and laterally spaced from one another by a spacing element. A handle can rotate in the plane of the supports, enabling a care giver to rotate a patient form a sitting to a lying position and then to roll the patient onto their back. Another embodiment provides a patient cradle for cradling a patient from a reclining to a sitting position and vice versa. | 2015-08-20 |
20150231011 | Universal Sterile Drape and Support System for In-Operating-Room Safe Patient Handling Equipment - Described are surgical drapes and system with universal application to heavy equipment useful in operating room environments. Surgical drape systems of the invention are particularly capable of covering patient support machinery such as hoists, lifts, and slings, whether the equipment is mobile or stationary, or configured as a floor-based or as an overhead support/lifting system. The drapes of the current invention provide for protecting the equipment from exposure to surgical biohazard waste e.g.; blood or body fluids, as well as providing the ability to use equipment that is otherwise not presently allowed to enter into an operating room because of the impossibility to render such equipment sterile. The drapes further allow for the holding, lifting and positioning of the patient whole body or limbs while maintaining sterility during prepping and surgical procedures. Also included are support slings for use with the drapes. | 2015-08-20 |
20150231012 | INCUBATOR DEPLOYABLE MULTI-FUNCTIONAL PANEL - An incubator including a plurality of panels. At least one of the panels, or portion thereof, is a multi functional panel that is reversibly connected to at least one of the plurality of panels. The incubator can be opened and closed. In a closed configuration, the incubator sealingly encloses an internal environment. In an open configuration, the multi-functional panel is deployable as a countertop. | 2015-08-20 |
20150231013 | APPARATUS FOR POSITIONING THE LOWER LIMB OF A PATIENT DURING OPERATION, IN PARTICULAR FOR HIP REPLACEMENT OPERATIONS WITH ANTERIOR APPROACH, AND SURGICAL POSITIONING SYSTEM COMPRISING SAID APPARATUS - Apparatus ( | 2015-08-20 |
20150231014 | MASSAGE TOOL WITH INTEGRATED TAPE CUTTER - A hand-held massage tool includes a grip, at least one surface adapted to massage a human body while the massage tool is held using the grip, and a tape cutter. The grip can include one or more openings in the massage tool, a textured portion of the massage tool, or a handle. The massage tool can include a plurality of surfaces adapted to massage a human body, each surface of the plurality of surfaces having a contour to correspond to a portion of a human body and a cross-sectional shape. The tape cutter can include at least one blade coupled to the massage tool having at least one position where the at least one blade is positioned to avoid cutting a finger. | 2015-08-20 |
20150231015 | HUNGER CONTROL ABDOMINAL BINDER - A hunger control abdominal binder may include a garment adapted to be worn about a midsection of a human subject. Embodiments may further include a pressure applicator element having a generally flat base portion and a generally round convex portion extending from a plane of the base portion. The pressure applicator may be reversibly attachable to a plurality of positions on the garment, and the pressure applicator may be positionable between the midsection of the human subject and the garment so that the garment and pressure applicator cooperate to apply pressure to the midsection. | 2015-08-20 |
20150231016 | Therapeutic Compression Apparatus - A massage and rehabilitation system utilizing therapeutic compression apparatuses and methods. Vertical and horizontal adjustments are incorporated, as well differing size, number and flexure massage heads. The massage and rehabilitation system affords the professional or user numerous degrees of adjustment. | 2015-08-20 |
20150231017 | EQUIPMENT FOR TREATING AND CARING FOR THE SPINAL COLUMN - The invention concerns therapeutic equipment for treating and caring for the spinal column, the equipment comprising: a support frame ( | 2015-08-20 |
20150231018 | WALK-ASSISTIVE APPARATUS AND METHOD OF CONTROLLING THE WALK-ASSISTIVE APPARATUS - Disclosed herein are a walk-assistive apparatus and a method of controlling the walk-assistive apparatus. The walk-assistive apparatus includes at least one joint that corresponds to at least one joint of a wearer, at least one link that connects the joint, and is rotated in response to rotation of the joint, a spring that is mounted in the link or the joint so that a length of the spring is changed in accordance with rotation of the link or the joint, and a processor that controls the change in the length of the spring to compensate for a weight by gravity when the wearer walks. | 2015-08-20 |
20150231019 | Walking Aid Support Assembly - A walking aid support assembly stably supports a leg of a user while using a crutch. The assembly includes a pair of mounting members each having a first flange and a second flange. Each of the second flanges is configured for coupling to a crutch frame. A support member is coupled to each of the first flanges. The support member is configured to support a leg of a user above a ground surface. Each of a pair of braces is coupled to and extends between the support member and an associated one of the mounting members. Each brace has a bottom portion and an upper portion. The bottom portion of each brace is coupled to the first flange of the associated mounting member below the support member. The upper portion of each brace is coupled to a front section of the support member positioned distally relative to the mounting members. | 2015-08-20 |
20150231020 | Automated Variable Zoom Software (AVZS) for Exercising the Eyes - A moving image-type eye exercise software, Automated Variable Zoom Software or AVZS, incorporated via software into a computing device visual task utilizing a window (graphical control element) such as reading, writing, graphics, games, etc. The software incorporation method is stand-alone application, incorporated module, or plug-in software application. The moving image is the window itself. The movements are repeated cyclically and constitute oscillations in the three fundamental directions: perpendicular to display (virtual), horizontal, and vertical. The oscillations are governed by code that ensures constant clarity and visually smooth and subtle transitions. These oscillations occur automatically, upon enabling AVZS, whilst the user is actively engaged in the visual task; thus, the user is able to alleviate eye strain and/or strengthen eyes without further burdening the eyes and without dedicating otherwise additional time and effort just to perform eye exercise. | 2015-08-20 |
20150231021 | METHOD AND SYSTEM TO EVACUATE ONE OR MORE DRESSINGS USING TWO OR MORE VACUUM PUMPS - Systems, apparatuses, and methods for providing a negative-pressure therapy system are described. The system includes a first dressing, a second dressing, and a negative-pressure source. The negative-pressure source includes a first pump and a second pump. A first valve is fluidly coupled to the first dressing and the first pump to selectively permit fluid communication to the first dressing. A second valve is fluidly coupled to the second dressing and the second pump to selectively permit fluid communication to the second dressing. A cross-over valve is fluidly coupled to the first pump, the first valve, the second pump, and the second valve. The cross-over valve permits fluid communication between the first pump and the second valve and/or the second pump and the first valve. A controller is communicatively coupled to the first pump, the second pump, the first valve, the second valve, and the cross-over valve for operating the same. | 2015-08-20 |
20150231022 | COMPRESSION GARMENT INFLATION - A compression garment includes a plurality of inflatable bladders, a valve body, an inlet, an exhaust, and a rotary valve. The plurality of inflatable bladders is positionable around a limb of a wearer. The manifold defines a plurality of bladder ports, each bladder port in fluid communication with a respective inflatable bladder. The inlet defines an inlet port, and the exhaust defines an exhaust port. The rotary valve is in fluid communication with the inlet port, the exhaust port, and the plurality of bladder ports. Rotation of the valve in a first direction controls fluid communication between the inlet port and the plurality of bladder ports, and rotation of the valve in a second direction, opposite the first direction, controls fluid communication between the exhaust port and the plurality of bladder ports. | 2015-08-20 |
20150231023 | BACK MASSAGING APPARATUS - In a back massaging apparatus capable of projecting a massaging mechanism forward and returning the same to an original normal position, upon securing a motion amount to be sufficient, the back massaging apparatus is intended to be thinned in the back and forth direction and allow a backrest part as a chair-type massaging machine to be suppressed from thickening. A back massaging apparatus ( | 2015-08-20 |
20150231024 | Wearable Massager for Couples - A remote-controllable wearable massager for couples including a first arm, a second arm, and a connecting member coupling the first arm to the second arm provides massaging motion for a user and can be used by the user during sexual intercourse with a partner. During operation, the first arm of the massager is inserted into the user's vagina and the second arm rests on the region near the user's clitoris. The connecting member is configurable such that the user can flexibly adjust the distance between the first arm and the second arm of the massager to allow for insertion of the first arm into a vagina, and rigid enough to forcibly compress the first arm towards the second arm, allowing the massager to be worn as a clip. During operation, the distal end of the first arm rotates about the intersection between the first arm and the connecting member. | 2015-08-20 |
20150231025 | RESPIRATORY TREATMENT DEVICE - A respiratory treatment device can include a removable cup portion configured to removably couple to a weighted head. The weighted head can be connected to a first end of a shaft. A second end of the shaft can be connected to a handle. A center of gravity of the device along a length of the device can be modified by increasing or decreasing the weight of the handle and/or of the weighted head. A user of the treatment device can tap a patient with the cup portion of the device. The weighted head can increase deflection in shaft of the device during use. | 2015-08-20 |
20150231026 | SYSTEMS AND METHODS FOR GRAVITY-ASSISTED CARDIOPULMONARY RESUSCITATION - Increasing blood circulation, lowering intracranial pressure, and increasing cerebral perfusion pressure during the administration of cardiopulmonary resuscitation by gravity-assist due to elevation of one or both of the torso and head of an individual. | 2015-08-20 |
20150231027 | SYSTEMS AND METHODS FOR GRAVITY-ASSISTED CARDIOPULMONARY RESUSCITATION - Increasing blood circulation, lowering intracranial pressure, and increasing cerebral perfusion pressure during the administration of cardiopulmonary resuscitation by gravity-assist due to elevation of one or both of the torso and head of an individual. | 2015-08-20 |
20150231028 | Method and Apparatus for Improved Ventilation and Cardio-Pulmonary Resuscitation - Apparatuses and methods are disclosed for improved ventilation and cardio-pulmonary resuscitation. An apparatus of the invention may include sealing means, a valve that is configured to the sealing means to control the airway of a patient, means to actuate the valve, a control unit coupled to the valve actuating means, and means to deliver mechanical compressions to the chest. The control unit is configured to actuate the valve and the mechanical compression means to affect a number of sequences of states. Further, an apparatus of the present invention may include an oxygen source, oxygen valve, and oxygen valve actuator. The apparatus may also include a means for measuring an anterior to posterior distance, airway pressure monitoring means, means to monitor exhaled carbon dioxide, and/or an inventive airway valve consistent with the described invention. | 2015-08-20 |
20150231029 | NOZZLES - This disclosure relates to nozzles, systems containing them and methods of using them. In particular, this disclosure relates to nozzles that can produce bubbles from a liquid saturated with gas. The nozzles can produce micro bubbles which are desirable in bathing. | 2015-08-20 |
20150231030 | Implantable Electroacupuncture System for Treating Cardiovascular Disease - An Implantable ElectroAcupuncture Device (IEAD) treats cardiovascular disease through application of stimulation pulses applied at at least one of acupoints EX-HN1, BL14, HT7, HT5, PC6, ST36, LI11, LU7, and LU2. The IEAD comprises an implantable, coin-sized, self-contained, leadless electroacupuncture device having at least two electrodes attached to an outside surface of its housing. The device generates stimulation pulses in accordance with a specified stimulation regimen. Power management circuitry within the device allows a primary battery, having a high internal impedance, to be used to power the device. The stimulation regimen generates stimulation pulses during a stimulation session of duration T | 2015-08-20 |
20150231031 | Blood Bag and Blood Bag System Provided Therewith - An initial flow blood bag ( | 2015-08-20 |
20150231032 | APPARATUS AND METHOD FOR BLOOD COLLECTION - A device and method for collecting blood are provided. The device comprises a housing configured to receive a blood source and a first collection means in communication with the housing, wherein the housing comprises a first output configured to allow passage of blood extracted from the blood source and/or at least a portion of the blood source therethrough. | 2015-08-20 |
20150231033 | Dilution Kit and Method - A method of diluting concentrated solutions used to treat allergic symptoms is disclosed. The method includes placing a predetermined amount of one of a diluent, a concentrated solution, and a combination thereof into an empty vial of a plurality of vials including an empty maintenance vial, a diluent vial, an intermediate vial and an empty start vial. The method further includes removing an amount of concentrated solution and placing the concentrated solution into an empty maintenance vial, removing an amount of diluent and placing a portion of the diluent from the diluent vial into each of the intermediate vial and the start vial, removing an amount of concentrated solution and placing the concentrated solution from the maintenance vial into the intermediate vial. The method still further includes removing an amount of solution from the intermediate vial and placing the solution from the intermediate vial into the start vial. | 2015-08-20 |
20150231034 | TELESCOPIC FEMALE DRUG VIAL ADAPTER - A telescopic female drug vial adapter including a spike component telescopically mounted on a skirt component for snap fit on and puncturing a drug vial in an actuated position. The telescopic female drug vial adapter is particularly suitable for implementation in a vented version to avoid wetting of its air filter during aspiration of liquid contents from a drug vial. | 2015-08-20 |
20150231035 | VENTED LIQUID CONTAINER - A vent system for a liquid container having a container body with a top dispensing opening and a bottom portion having coupling elements and a bottom opening, the vent system including a solid closure member for closing the bottom opening; a sealing member disposed in the closure member, the sealing member including a sealing element configured to seal a rim of the container bottom opening and having a bore, and a one-way valve sealing the bore against liquid passage from the container and selectively permitting air passage through the bore into the container; complementary coupling elements on the closure member for coupling to the coupling elements on the bottom portion of the container, configured so that ambient air can enter between the container body and the closure member; and an air conduit extending from the coupling elements to a space in the vent system which is in operative communication with the bore, and a method for making it. | 2015-08-20 |
20150231036 | INFANT BOTTLE ASSEMBLY HAVING A VENTED NIPPLE - A nipple for use with a bottle assembly includes a base portion that has a bottom surface, a vent region that is coupled to and extends upward from the base portion of the nipple, and a nipple portion that extends upward from the vent region. The nipple portion includes an outlet opening therein, and the vent region includes a vent channel and an air valve substantially aligned with the vent channel. | 2015-08-20 |
20150231037 | FEEDING TUBE INSERTION DEVICE - A feeding tube placement device comprising a shaft and a functional tip which can be removably attached to a feeding tube, and which is used by insertion into a small animal's mouth then through the wall of the esophagus where a feeding tube is attached and then drawn back into the esophagus and positioned for use in feeding. | 2015-08-20 |
20150231038 | APPARATUS AND METHODS FOR ORAL ADMINISTRATION OF FLUIDS AND MEDICAL INSTRUMENTATION - Methods and devices for orally administering fluids and medical instrumentation to individuals for the promotion of health are disclosed. An apparatus is described comprising a nipple base, a passage extending through the nipple base, and a nipple, integrally formed with, and extending proximally from, the nipple base. The nipple is defined by a contoured nipple wall having a nipple aperture disposed on a proximal end of the nipple wall. There is a receiving tube extending through the nipple and the passage. The receiving tube terminates at the nipple aperture which is offset from a central axis of the nipple, in certain embodiments, along an axis that forms an angle between 1° and 120° with a central axis of the nipple. The receiving tube is disposed along a longitudinal axis that is offset from the central axis. The nipple, the nipple base, and the receiving tube form a unitary monolithic body. | 2015-08-20 |
20150231039 | Apparatus for Containing Regurgitation - An apparatus used to contain waste for sanitary disposal by a user after experiencing nausea alone or in combination with diarrhea. The tray includes a bag dispensing system providing isolation between the user and the waste. The tray can be attached to a wide variety of objects thereby enabling sanitary containment in many locations. | 2015-08-20 |
20150231040 | DENTAL COMPOSITION - Dental composition comprising (i) a particulate filler; (ii) a polymerizable hydrolysis-stable compound of the following formula (1) AX | 2015-08-20 |
20150231041 | Radically Polymerisable Dental Material, Cured Product and Usage - The invention relates to a polymerizable dental material containing a) at least one curable aliphatic and/or cycloaliphatic monomer system having a refractive index that is measured at 23° C. and a wavelength of 589 nm of less than or equal to 1.50 that contains at least one aliphatic and/or cycloaliphatic bis(meth)acrylate and/or at least one aliphatic and/or cycloaliphatic bis(meth)acrylamide; and b) 15 to 80% by weight relative to the total mass of the dental material of at least one filler selected from the group of fused silica having a refractive index that is measured at 23° C. and a wavelength of 589 nm of 1.45 to 1.47, or cristobalite with a refractive index that is measured at 23° C. and a wavelength of 589 nm of 1.48 to 1.49, or combinations thereof. The radically polymerizable dental material has excellent storage properties and is formulated, in particular, as a two-component mixture containing components A and B. Subsequent to mixing components A and B, the polymerizable mixture cures quickly in the conditions present in the mouth and forms cured masses having outstanding mechanical and optical properties. The cured products can be used, in particular, for producing crowns and bridge material and as core buildup material. | 2015-08-20 |
20150231042 | SKIN CLEANSING COMPOSITIONS COMPRISING BIODEGRADABLE ABRASIVE PARTICLES - The present invention relates to a skin cleansing composition, preferably a facial cleanser, comprising biodegradable abrasive particles having a mean Circularity of from about 0.60 to 0.90, a mean Solidity from about 0.60 to about 1.0, and a Biodegradable Rate of at least about 30% as determined after 28 days. In a preferred embodiment, the total skin cleansing composition has a Biodegradable Rate of at least 60% as determined after 90 days. | 2015-08-20 |
20150231043 | SUNSCREEN COSMETIC - The present invention is a sunscreen cosmetic comprising the following components (A) through (E):
| 2015-08-20 |
20150231044 | COSMETIC POWDER - What is claimed is: a loose cosmetic powder, comprising: a base component including particles that include one or more of talc, mica, zinc stearate, boron nitride, and one or more pigments; and color bits, wherein the loose cosmetic powder displays a color change when subjected to an application of pressure. | 2015-08-20 |
20150231045 | ANTI-DANDRUFF COMPOSITION COMPRISING 1-ACETOXYCHAVICOL ACETATE - The present invention relates to an anti-dandruff composition comprising 1-acetoxychavicol acetate (I). Furthermore, the present invention relates to a method for preparing said anti-dandruff composition and the use of said anti-dandruff composition for treating or preventing | 2015-08-20 |
20150231046 | Composition Containing a Cellulose Derived Capsule With a Sunscreen - A sunscreen composition comprised of one or more sunscreen active agents encapsulated in a cellulose derived capsule wherein the composition can contain one or more additional agents. A sunscreen composition can be mixed with a bodywash, shampoo, conditioner, lotion, gel, soap, cream, hand sanitizer, spray or mousse and can be used by an individual during their normal hygiene processes, such as during a shower or bath or while applying a body product to their skin or hair. | 2015-08-20 |
20150231047 | EXOTHERMIC HAIR COLOR COMPOSITION - A composition for coloring hair is disclosed. The composition comprises, in a cosmetically acceptable solvent, at least one reducing agent with a concentration up to 2 wt. % of the composition, preferably up to 1 wt. %. Optionally, the composition comprises at least one coloring agent. The composition is free of ammonia and free of p-phenylenediamine (PPD). The mixing of the composition for coloring hair with an oxidizing composition launches an exothermic chemical reaction providing heat with a temperature that increases from room temperature TR to a temperature ranging from about (T | 2015-08-20 |
20150231048 | Method of Maintaining Oral Health in Animals - Use of a compound having the formula (I) in the manufacture of a medicament for the prevention or treatment of a diseased caused by oral bacterial in an animal Formula (I); wherein R | 2015-08-20 |
20150231049 | Cosmetic Use of N-Heteroarylbisamide Analogs and Related Compounds - Cosmetic and dermatological compositions comprising N-heteroarylbisamide analogs and methods of using such compositions to impart anti-aging benefits to the skin and/or improve skin conditions resulting from reduced collagen and hyaluronic acid production are disclosed. The N-heteroarylbisamides are believed to stimulate collagen and hyaluronic acid production and restore or maintain homeostasis for these compounds. | 2015-08-20 |
20150231050 | HAIR DYE PRODUCT - The invention relates to a hair dye product, in particular to a hair dye product comprising at least two natural dye substances, and the use of the at least two natural dye substances in human or animal hair dyeing or in preparation of hair dye product for human or animal, wherein at least one of the natural dye substances displays yellow or yellowish brown color series; preferably, the natural dye substance displaying the yellow or yellowish brown color series is selected from quercetin or a derivative thereof, or an extract containing the quercetin or the derivative thereof, or a mixture thereof. The at least two natural dye substances of the invention are combined as dyeing ingredient, compared with those used alone, the range of the color is very different, and the color of the dyed hair is natural, which is yellowish black and consistent with human real hair, moreover, the hair dyeing effect is stable and the color is not easy to fade. | 2015-08-20 |
20150231051 | OPEN CHAINED OR FUSED 1,1 '-ALKYLENE-BIS-URACIL DERIVATIVES, USEFUL IN SKIN UV-PROTECTION - The invention provides compounds of formula I; or a salt thereof as described herein. The invention also provides dermatological compositions comprising a compound of formula I or mixtures of one or more compounds of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods for protecting skin or DNA from photodamage or repairing photodamaged skin or DNA. | 2015-08-20 |
20150231052 | MESENCHYMAL STEM CELL EXTRACT AND ITS USE - A mesenchymal stem cell extract and its use are provided, wherein the mesenchymal stem cell extract comprises a trophic factor(s), such as bone morphogenetic protein-7 (BMP-7), stromal cell-derived factor-1 (SDF-1), vascular endothelial growth factor (VEGF), C-X-C chemokine receptor type-4 (CXCR4), brain-derived neurotrophic factor (BDNF), and/or interleukin-17 (IL-17), and wherein the extract is especially suitable for repairing skin aging. | 2015-08-20 |
20150231053 | TREATMENT OF SKIN, INCLUDING AGING SKIN, TO IMPROVE APPEARANCE - The present invention generally relates to compositions and methods for topical or transdermal delivery, treatment of skin, and improving the appearance of skin, e.g., medically or cosmetically. In some cases, the composition may include nitric oxide and/or peptides such as thyrotropin-releasing hormone (TRH) and/or GnRH (gonadotropin-releasing hormone). The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other structures containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like. | 2015-08-20 |
20150231054 | COPOLYMERS IN COSMETIC COMPOSITIONS - The present invention concerns the use of a specific copolymer to homogenize compositions that include coloring pigments and/or pearlescent pigments and film-forming polymers, as well as the cosmetic compositions containing said copolymer. | 2015-08-20 |
20150231055 | COMPOSITE PARTICLE AND A COSMETIC COMPOSITION CONTAINING THE SAME - The present application provides a composite particle having a good feeling upon application and capable of effectively preventing make-up smudges by selectively adsorbing sebum, particularly, free fatty acid, and moreover, having a toning effect on the skin texture, and a cosmetic composition containing the composite particle. The composite particle of the present invention comprises a resin particle coated on its surface with amorphous calcium phosphate and calcium carbonate, which resin particle contains a polymer of a vinyl monomer and any one of a phosphorous acid diester component having a certain configuration and a partially esterified phosphoric acid component having a certain configuration. | 2015-08-20 |
20150231056 | 2-PART HAIR COSMETIC - The present invention provides a two-part hair cosmetic material having a reduced irritating smell due to ammonia. Specifically, the present invention relates to a two-part hair cosmetic material comprising a first agent containing an alkali agent and a second agent containing an oxidizing agent, wherein the first agent contains the following ingredients: (A) a polyoxyethylene alkyl ether having a polyoxyethylene chain length of 50 or more, (B) a higher alcohol, and (C) a polyoxyethylene alkyl ether having a polyoxyethylene chain length shorter than the polyoxyethylene chain length of the polyoxyethylene alkyl ether (A), and the content of a higher alcohol having 20 or more carbon atoms in the higher alcohol (B) is 1.0% by weight or less based on the weight of the first agent. | 2015-08-20 |
20150231057 | COSMETIC USE OF THE ESSENTIAL OIL OF LASERPITIUM SILER L. AGAINST THE SIGNS OF AGING OF THE SKIN AND AS A SKIN ANTIOXIDANT - The present invention relates to the cosmetic use of the essential oil of | 2015-08-20 |
20150231058 | QUICK-PENETRATING SOFT SKIN-CARE CREAM - The invention pertains to the field of cosmetic and/or dermatological compositions and relates to quick-penetrating skin care compositions for topical application to human skin, containing wax components, carbomers, certain fatty alcohols, emollients, certain fatty acid and fatty alcohol esters, and at least one active ingredient selected from among creatine, allantoin, and/or glycerin. The invention further relates to methods for the production and to uses of such compositions. | 2015-08-20 |
20150231059 | Particle-Free Microdermabrasion Formulations - An exemplary embodiment provides a particulate-free microdermabrasion formulation that includes a emulsifying agent; an ionic salt; a moisturizer; a neutralizer; and water. The formulation is free of acids, abrasive particulates, and enzymes. Further, upon application of the formulation to the skin surface, the formulation forms a thin layer that coats the skin surface and penetrates into pores of the skin. The thin layer sloughs off upon light rubbing, for example by hand or with a soft cloth or wipe, thereby removing dead skin cells and debris from the skin surface to leave a smooth, moisturized newly exposed skin surface. | 2015-08-20 |
20150231060 | COMPOSITIONS FOR TREATMENT OF XEROSTOMIA AND FOR TOOTH TREATMENT - The present application provides an oral care composition comprising:
| 2015-08-20 |
20150231061 | USE OF SPIDER VENOMS FOR SKIN WHITENING/DEPIGMENTING AND COMPOSITION COMPRISING SPIDER VENOMS MOLECULES OR SYNTHETIC ANALOGS - The use of spider venom, molecules or synthetic analogs thereof for skin whitening. Also, compositions that include spider venom, molecules or synthetic analogs thereof for skin whitening/depigmenting, and a non-therapeutic method for whitening human skin that includes topically applying an effective amount on human skin of the composition. | 2015-08-20 |
20150231062 | TWO-PIECE, INTERNAL-CHANNEL OSMOTIC DELIVERY SYSTEM FLOW MODULATOR - An osmotic delivery system flow modulator includes an outer shell constructed and arranged for positioning in an opening, an inner core inserted in the outer shell, and a fluid channel having a spiral shape defined between the outer shell and the inner core. The fluid channel is adapted for delivery of an active agent formulation from the reservoir of the osmotic delivery system. | 2015-08-20 |
20150231063 | Pharmaceutical Compositions Comprising Flurbiprofen - The present invention provides an NSAID such as ibuprofen or flurbiprofen, or a pharmaceutically acceptable salt thereof for use in the topical treatment of coughs, especially dry coughs. | 2015-08-20 |
20150231064 | METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES - This invention relates to, in part, methods and compositions that are useful for the diagnosis, treatment, or prevention of a blinding eye disease, including in the discovery of drugs that are efficacious against these diseases. Diseases include, for example, age related macular degeneration and reticular pseudodrusen disease, and the methods described herein include, for example, the method named delayed near infrared analysis (DNIRA). | 2015-08-20 |
20150231065 | ORODISPERSIBLE FILMS HAVING QUICK DISSOLUTION TIMES FOR THERAPEUTIC AND FOOD USE - The present invention concerns an orodispersible self-supporting film free from hydrocolloids comprising: a) a film-forming substance consisting of a maltodextrin in an amount comprised between 40 and 80% by weight; b) a plasticizer in an amount comprised between 15 and 55% by weight; e) a surfactant System in an amount comprised between 0.5 and 6% by weight; d) an active ingredient for food or therapeutic use in an amount between 0.05 and 30% by weight, characterised in that it contains a homopolymer or a copolymer of vinyl acetate in a quantity comprised between 2 and 10% by weight where the percentages are calculated on the total weight of said film | 2015-08-20 |
20150231066 | MONOVALENT METAL CATION DRY POWDERS FOR INHALATION - The present invention is directed toward respirable dry powders and particles for systemic delivery of pharmaceutically active agents or delivery to the respiratory tract. The dry powders contain one or more monovalent metal cations (such as Na | 2015-08-20 |
20150231067 | METHOD AND COMPOSITION FOR TREATING HYPERGLYCEMIA - Compositions and methods for treating diseases and or disorders, including hyperglycemia and/or diabetes, and obesity in a subject are provided. In particular, a dry powder oral inhalation system is provided comprising, a dry powder composition of GLP-1 analogs, including PEGylated-GLP-1 molecules and a diketopiperazine. | 2015-08-20 |
20150231068 | Treatment of Migraine Headaches with Presynaptic Neurotoxin - The present invention provides a method for treating a patient for migraine headache, including symptoms associated with migraine headache, such as migraine associated vertigo, which comprises administering to the patient a therapeutically effective amount of an invertebrate presynaptic neurotoxin, e.g. Botulinum toxin in a pharmaceutically safe form. | 2015-08-20 |
20150231069 | ORAL FORMULATIONS OF CHEMOTHERAPEUTIC AGENTS - A composition and method of using the composition for treating a patient in need thereof, the composition comprising an oral formulation for enhanced bioavailability of therapeutic agents such as the taxane chemotherapeutic agents. The composition comprises the therapeutic agent and an absorption enhancing agent either co-administered with the agent or administered separately, the therapeutic agent in a polymer matrix resulting in a microbead and including an edible oil resulting in an emulsion. The absorption enhancing agent is a cyclosporin in one embodiment. The absorption enhancing agent is a P glycoprotein inhibitor in another embodiment. | 2015-08-20 |
20150231070 | Compositions for Nanoemulsion Delivery Systems - The present disclosure provides a pharmaceutically acceptable, stable, and optically clear oil-in-water nanoemulsions (intensity-averaged diameter<100 nm) with an oil phase comprising >10% w/v of long chain triglyceride, total surfactant and cosurfactant concentration less than that of oil phase and without the use of alcohol as cosolvent in the aqueous phase. The nanoemulsions of this disclosure have extremely favorable particle size distribution, optical clarity, and product stability against Ostwald ripening with high levels of oil concentrations. Poorly water soluble, therapeutically active agents and others can be incorporated in the nanoemulsion systems to improve their solubility/stability in aqueous medium or to enhance their delivery for use in pharmaceutical, food, cosmetic, and other applications by oral, intravenous, subcutaneous, intra muscular, inhalation, nasal, topical, ocular, and transdermal routes. | 2015-08-20 |
20150231071 | Sprayable Composition Containing Zinc Oxide and a Fluoro-Olefin Propellant - A sprayable zinc oxide composition is provided. The sprayable zinc oxide composition can be used in the treatment of various skin conditions. The sprayable zinc oxide composition includes zinc oxide particles and a fluoro-olefin propellant. The present inventors have found that by selecting a propellant having a certain specific gravity, vapor pressure, and molecular weight, and by controlling the viscosity of the various components of the composition, the resulting zinc oxide composition resists settling such that a substantially homogeneous distribution of zinc oxide particles is maintained and can be evenly sprayed onto a surface without running once applied. | 2015-08-20 |
20150231072 | Stabilized, Sprayable Emulsion Containing Active Agent Particles - A sprayable emulsion is provided. The emulsion can be used in the treatment of various skin conditions. The emulsion includes a hydrofluoro-based propellant, an emulsification system, an oil phase, a water phase, and active agent particles. Further, the emulsification system includes at least one nonionic emulsifier. The emulsion has a viscosity ranging from about 500 centipoise to about 10,000 centipoise and a hydrophilic to lipophilic balance (HLB) value of from about 2 to about 12. The present inventors have found that by selectively controlling the nature of the emulsification system and the viscosity of the emulsion, the active agent particles resist settling such that a substantially homogeneous distribution of the active agent particles is maintained and can be evenly sprayed onto a surface without running once applied. | 2015-08-20 |
20150231073 | AMPHOTERIC LIPOSOMES - A serum-stable mixture of lipids capable of encapsulating an active agent to form a liposome, said mixture comprising phosphatidylcholine and phosphatidylethanolamine in a ratio in the range of about 0.5 to about 8. The mixture may also include pH sensitive anionic and cationic amphiphiles, such that the mixture is amphoteric, being negatively charged or neutral at pH 7.4 and positively charged at pH 4. Amphoteric liposomes comprising such a mixture may be used for encapsulating nucleic acid therapeutics, such as oligonucleotides and DNA plasmids. The drug/lipid ratio may be adjusted to target the liposomes to particular organs or other sites in the body. | 2015-08-20 |
20150231074 | INTERNAL STRUCTURED SELF ASSEMBLING LIPOSOMES - The specification relates to an internal structured self assembled liposome (ISSAL), containing a nuclear core molecule or complex including a first affinity enhancing molecule; and a phospholipid-affinity enhancing complex having a phospholipid coupled to second affinity enhancing molecule, wherein the second affinity enhancing molecule couples to the first affinity enhancing molecule. The ISSAL's can be used in, for example and without limitation, the field of drug delivery, vaccination, imaging contrast agents, and nanotechnology, in which liposomes of ordered, self-assembling structure are employed to deliver soluble or insoluble molecules to any sub-cellular address. | 2015-08-20 |
20150231075 | RAPIDLY DEGRADING EMBOLIC PARTICLES WITH THERAPEUTIC AGENT RELEASE - In accordance with one aspect, embolic particles are provided which comprise sub-particles that comprise a therapeutic agent of low solubility dispersed in a matrix that comprises a biodegradable polymer. Other aspects pertain to injectable compositions that comprise such particles and to methods of treatment that employ such injectable compositions. Still other aspects pertain to methods of making such particles. | 2015-08-20 |
20150231076 | ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLE AND METHOD FOR PRODUCING ORAL SOLID PREPARATION COMPRISING ARIPIPRAZOLE - [Object] An object of the present invention is to provide an oral solid preparation that can be produced in a simpler manner than conventional methods, that exhibits high bioavailability and high dissolubility even in persons having low stomach acid, and that can also ensure dissolubility after being allowed to stand for a certain period of time. Another object is to provide a simple method for producing the oral solid preparation. | 2015-08-20 |
20150231077 | AMINE PASSIVATED NANOPARTICLES FOR CANCER TREATMENT AND IMAGING - Amine-passivated gold nanoparticles and methods of making and using such nanoparticles are described. The nanoparticles can be prepared in a manner in which amine-containing drugs or imaging agents associate with the surface of the nanoparticles to allow delivery of the drugs or agents in vivo, but the association is weak enough to allow the amine-containing drug or imaging agents to be released from the nanoparticle upon reaching its target. Amine passivated gold nanoparticles including targeting molecules which are attached through a thiol linkage can also be prepared and used. | 2015-08-20 |
20150231078 | GASTRORETENTIVE DRUG FORMULATION AND DELIVERY SYSTEMS AND THEIR METHOD OF PREPARATION USING FUNCTIONALIZED CALCIUM CARBONATE - An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source. | 2015-08-20 |
20150231079 | Pharmaceutical Antiretroviral Composition - A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug. | 2015-08-20 |
20150231080 | PHARMACEUTICAL COMPOSITION COMPRISING AN ATYPICAL ANTIPSYCHOTIC AGENT AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to a solid dosage form for oral administration comprising a therapeutically effective amount of an atypical antipsychotic agent or a pharmaceutically acceptable salt, in particular Quetiapine, incorporated in a matrix formed by non-gelling polymers. It also relates to a process for the preparation thereof. | 2015-08-20 |
20150231081 | DELAYED RELEASE POSACONAZOLE TABLETS - The present invention relates to a delayed release composition comprising Posaconazole dissolved or molecularly dispersed in a polymer other than a hydroxypropyl methylcellulose derived polymer; wherein the composition is prepared by hot melt extruding an admixture of Posaconazole and the polymer. The present invention also provides a process of preparing said composition. | 2015-08-20 |
20150231082 | HYDROXYALKYLALKYL CELLULOSE FOR TABLETING AND SOLID PREPARATION COMPRISING THE SAME - Provided are a hydroxyalkylalkyl cellulose excellent in formability and not causing marked delay in disintegration when added even in a small amount; a solid preparation including the hydroxyalkylalkyl cellulose; and a method for producing the solid preparation. More specifically, provided are a hydroxyalkylalkyl cellulose for tableting having a specific surface area of from 0.5 to 5.0 m | 2015-08-20 |
20150231083 | HYDROMORPHONE HYDROCHLORIDE-CONTAINING ORAL SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION - An object is to provide a hydromorphone hydrochloride- or oxycodone hydrochloride hydrate-containing sustained-release pharmaceutical composition for oral administration that reliably exhibits its main pharmacological effect and has excellent formulation stability that avoids dose dumping of the principal drug, such as alcohol resistance. The present invention provides a sustained-release pharmaceutical composition comprising (A) hydromorphone hydrochloride or oxycodone hydrochloride hydrate, (B) hydroxypropyl methylcellulose acetate succinate having a median size (D | 2015-08-20 |
20150231084 | OSMOTIC FLOATING TABLETS - The present invention relates to an osmotic floating tablet comprising: (i) an inner core comprising a drug, one or more low density polymers, and one or more pharmaceutically acceptable excipients; and (ii) an outer osmotic coating surrounding the inner core that is substantially permeable to surrounding fluids and substantially impermeable to the drug. The present invention also relates to processes for the preparation of said tablets. | 2015-08-20 |
20150231085 | PHARMACEUTICAL COMPOSITE CAPSULE FORMULATION COMPRISING IRBESARTAN AND HMG-COA REDUCTASE INHIBITOR - Disclosed are a pharmaceutical composite capsule formulation comprising 1) an independent irbesartan unit comprising irbesartan or a pharmaceutically acceptable salt thereof; and 2) an independent HMG-CoA reductase inhibitor unit comprising an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, and an alkaline additive, wherein said independent units are separated from each other within a capsule, and a method for preparing the same. Designed to prevent an interaction between irbesartan and the HMG-CoA reductase inhibitor, the pharmaceutical composite capsule formulation is improved in stability and dissolution rate, and thus shows great bioavailability. In addition, the formulation is expected to guarantee high drug compliance owing to its small size, and therefore can be applied to the treatment of hypertension and hypercholesterolemia. | 2015-08-20 |
20150231087 | TARGETED POORLY WATER-SOLUBLE DRUG DELIVERY SYSTEM, METHOD OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME - Provided are a poorly water-soluble drug delivery system, a method of preparing the same, a method of delivering a poorly water-soluble drug using the same, and a pharmaceutical composition including the same as an effective component, and more particularly, a poorly water-soluble drug delivery system aiming cancer cell specific targeting, which may variously control the kind of a cancer cell targeting material capable of specifically reacting to an antigen overexpressed in a cancer cell, thereby binding to the surface of the poorly water-soluble drug delivery system, and variously control the kind of a poorly water-soluble drug encapsulated therein depending on the kind of cancer and a therapeutic purpose, thereby being effectively applicable to a cancer treatment method. | 2015-08-20 |
20150231088 | METHYLPHENIDATE PATCH PREPARATION - Provided is a methylphenidate patch preparation superior in the stability of a drug (methylphenidate and/or a salt thereof) in the patch preparation, skin permeability of a drug during use of the patch preparation, and methylphenidate availability. A patch preparation having a support and an adhesive layer formed on at least one surface of the support, wherein the adhesive layer contains methylphenidate and/or a salt thereof, polyisobutylene and a liquid plasticizer. The liquid plasticizer preferably has an HLB value of 1.0-3.3. | 2015-08-20 |
20150231089 | COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING A MIXTURE OF FISH OIL AND FISH OIL DERIVED, CHOLINE BASED, PHOSPHOLIPID BOUND FATTY ACID MIXTURE INCLUDING POLYUNSATURATED EPA AND DHA - Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline based, phospholipid bound fatty acid mixture including polyunsaturated EPA and DHA either alone or in combination with other active constituents, including astaxanthin and polymeric hyaluronic acid or sodium hyaluronate (hyaluronan) in an oral dosage form. | 2015-08-20 |
20150231090 | USAGE OF GUTTIFERONE K FOR TREATING HIGH METASTATIC CANCER - The present invention provides composition for treating cancer comprising polyprenylated acylphloroglucinol (PPAP) compound. The present invention also provides a composition comprising Guttiferone K for treating esophageal cancer and liver cancer. The present invention further provides a method of using said compound for inhibiting cancer metastasis. | 2015-08-20 |